Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad111.
Some studies have linked late-life overweight to a reduced mortality risk compared to normal body mass index (BMI). However, the impact of late-life overweight and its combination with mid-life BMI status on healthy survival remains unclear. We aimed to investigate whether and to what extent mid- and/or late-life overweight are associated with chronic disease-free survival.
Within the Swedish Twin Registry, 11 597 chronic disease-free twins aged 60-79 years at baseline were followed up for 18 years. BMI (kg/m2) was recorded at baseline and 25-35 years before baseline (ie, midlife) and divided as underweight (<20), normal (≥20-25), overweight (≥25-30), and obese (≥30). Incident chronic diseases (cardiovascular diseases, type 2 diabetes, and cancer) and deaths were ascertained via registries. Chronic disease-free survival was defined as years lived until the occurrence of any chronic diseases or death. Data were analyzed using multistate survival analysis.
Of all participants, 5 640 (48.6%) were overweight/obese at baseline. During the follow-up, 8 772 (75.6%) participants developed at least 1 chronic disease or died. Compared to normal BMI, late-life overweight and obesity were associated with 1.1 (95% CI, 0.3, 2.0) and 2.6 (1.6, 3.5) years shorter chronic disease-free survival. Compared to normal BMI through mid- to late life, consistent overweight/obesity and overweight/obesity only in mid-life led to 2.2 (1.0, 3.4) and 2.6 (0.7, 4.4) years shorter disease-free survival, respectively.
Late-life overweight and obesity may shorten disease-free survival. Further research is needed to determine whether preventing overweight/obesity from mid- to late life might favor longer and healthier survival.
一些研究将晚年超重与正常体重指数(BMI)相比降低死亡风险联系起来。然而,晚年超重及其与中年 BMI 状况的结合对健康生存的影响尚不清楚。我们旨在研究中年和/或晚年超重是否与无慢性疾病生存有关。
在瑞典双胞胎登记处,11597 名无慢性疾病的双胞胎在基线时年龄为 60-79 岁,随访 18 年。BMI(kg/m2)在基线时和基线前 25-35 年(即中年)记录,并分为消瘦(<20)、正常(≥20-25)、超重(≥25-30)和肥胖(≥30)。通过登记处确定新发慢性疾病(心血管疾病、2 型糖尿病和癌症)和死亡。无慢性疾病生存定义为出现任何慢性疾病或死亡前的生存年限。使用多状态生存分析对数据进行分析。
所有参与者中,5640 人(48.6%)在基线时超重/肥胖。在随访期间,8772 名(75.6%)参与者至少发生 1 种慢性疾病或死亡。与正常 BMI 相比,晚年超重和肥胖与无慢性疾病生存分别缩短 1.1(95%CI,0.3,2.0)和 2.6(1.6,3.5)年。与中年至晚年持续超重/肥胖相比,中年仅超重/肥胖分别导致无慢性疾病生存缩短 2.2(1.0,3.4)和 2.6(0.7,4.4)年。
晚年超重和肥胖可能会缩短无慢性疾病生存。需要进一步研究以确定从中年到晚年预防超重/肥胖是否有助于更长和更健康的生存。